Navigation Links
DURABLE Clinical Trial Results Show GlycoMark is Key Test for Managing Patients with Diabetes
Date:6/7/2008

Additional Studies Indicate GlycoMark May Be a More Effective Monitor Than Hemoglobin A1C of Exenatide, Sitagliptin, Pramlintide and Prandial Insulin

Therapies in Certain Diabetic Populations

SAN FRANCISCO, June 7 /PRNewswire/ -- GlycoMark, Inc. announced today results from the ongoing DURABLE clinical trial showing that the GlycoMark blood test is a better reflection of glucose, particularly after-meal glucose levels, than the gold standard hemoglobin A1C test in moderately controlled patients with diabetes. These findings were reported by Kathleen Dungan, MD, of Ohio State University (Columbus, OH) and investigators from Eli Lilly (Indianapolis, IN) at the American Diabetes Association's 68th Annual Scientific Sessions (ADA) in San Francisco.

This is the largest clinical study to evaluate the clinical utility of GlycoMark to reflect after-meal glucose levels with 2,094 patients enrolled from 11 countries. The DURABLE trial (Assessing the Durability of Basal vs. Lispro Mix 75/25 Insulin Efficacy) confirms results from a smaller population study completed by John Buse, MD (University of North Carolina), Steven Wittlin, MD (University of Rochester), and Kathleen Dungan, MD, published in the medical journal Diabetes Care in June 2006.

In the study, the 1,5-Anhydroglucitol blood test (GlycoMark) correlated more strongly than hemoglobin A1C with all self-monitored plasma glucose (SMPG) parameters, particularly after-meal glucose levels, in moderately controlled patients with A1C levels less than 8.0%. Dr. Dungan concluded, "The data support the use of 1,5-anhydroglucitol, in conjunction with A1C, in moderately controlled patients with type 2 diabetes."

"This large clinical study validates the important role of the GlycoMark test to effectively monitor patients with diabetes," said Eric Button, President of GlycoMark, Inc. "Although patients may appear to be adequately controlled by A1C results, it may not readily revea
'/>"/>

SOURCE GlycoMark, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Micromets BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkins Lymphoma
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients
4. Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease
5. Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products
6. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
7. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
8. TorreyPines Therapeutics Initiates Clinical Trial to Evaluate Analgesic Effect of Oral Prodrug of Tezampanel
9. Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172
10. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
11. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... -- According to a new market research ... (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral), by ... to 2020", published by MarketsandMarkets, the Transfection Reagents and ... by 2020 with a CAGR of 7.2% from 2014 ... ables and 33 F igures ...
(Date:7/1/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/nk3569/future_horizons ... "Future Horizons and Growth Strategies in the European ... Forecasts" report to their offering. ... Blood Banking Market 2015 is a new five-countrystrategic ... and potential market entrants identify and evaluate emerging ...
(Date:7/1/2015)... MARLBOROUGH, Mass. , July 1, 2015 Boston ... call discussing financial results and business highlights for the second ... at 8 a.m. ET. The call will be ... officer, and Dan Brennan , executive vice president and ... conference call will be available via the Boston Scientific website. ...
Breaking Medicine Technology:Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 2Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 3Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 4European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 2European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 3Boston Scientific To Webcast Second Quarter 2015 Earnings Call On July 23 2
... TechniScan (OTC Bulletin Board: TSNI ), a ... an automated 3D breast ultrasound imaging system, announced today that ... with Austin, Texas-based Womens3D. These agreements follow ... January 2011 in which they agreed to jointly develop a ...
... PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ... company,s president and chief executive officer, is scheduled ... Markets Healthcare ConferenceWednesday, March 2, 20119:00 a.m. Eastern ... Health Care Conference Tuesday, March 8, 201111:00 a.m. ...
Cached Medicine Technology:Breast Imaging Company, TechniScan, Signs Manufacturing Agreement With Texas Company 2
(Date:7/1/2015)... ... 01, 2015 , ... After conducting a nationwide executive ... Medical Center in Oceanside, Calif., has hired Cheryle Bernard-Shaw as chief compliance ... adaptation efforts and growing a focus on risk management, Bernard-Shaw will assume her ...
(Date:7/1/2015)... ... ... Incentivizing the use of generic drugs has been an easy way for plans ... off the prices for the brand-name products. But now that generics are experiencing record ... these high-cost generic drugs. The July issue of Atlantic Information Services, Inc.’s (AIS) The ...
(Date:7/1/2015)... ... 01, 2015 , ... Northbound Treatment Services announced today that ... , Emily originally entered the behavioral healthcare industry as an academic director ... curriculum for clients to engage in their educational journey while in treatment. In ...
(Date:7/1/2015)... ... ... Thule Atmos X4 offers protection with minimal bulk. At the Thule Test Center™, ... Due to its Bi-ComponentArmor and ShockStop corners, it passed Thule’s 2 meter drop test, ... The Thule Atmos X4 has also been designed with function in mind. The ...
(Date:7/1/2015)... Raton, FL (PRWEB) , ... July 01, 2015 , ... ... wide range of nutritional and beauty products, recently attended the 2015 ECRM Diet, Vitamin ... big-time connections in the retail industry. The ECRM trade show allows companies ...
Breaking Medicine News(10 mins):Health News:Tri-City Medical Center Hires New Chief Compliance Officer 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 3Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 2Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 3Health News:Northbound Treatment Services Welcomes Emily Orrick as Director of Referral Relations 2Health News:NPI Meets With Top Retail Figures at ECRM Conference 2
... , THURSDAY, Sept. 15 (HealthDay News) -- Children typically don,t die ... Thursday that 115 kids younger than 18 died from flu-related causes ... many of the deaths could have been prevented if the children ... U.S. Centers for Disease Control and Prevention. , , ...
... protein linked to cell division and migration and tied to ... high levels in breast cancer specimens and cell lines. The ... in breast cancer cells than in normal breast cells. ... findings and others in a paper now online in the ...
... News) -- Experts around the world have issued a call ... A group of international medical bodies said physicians can ... and it also urged governments to take action and address ... in preventable and premature disease, affecting 76 million people globally. ...
... Clinic have received a grant from the National Institutes of ... test that conclusively identifies concussions in college football players. ... after a game searches for a biomarker known as ... in an athlete,s blood. Damir Janigro, Ph.D., and Nicola ...
... -- Not enough children and teens drink low-fat milk, a ... Prevention reveals. Drinking milk is important for children,s bone ... the calcium, vitamin D and other nutrients found in milk, ... milk products to avoid unnecessary fat and calories. ...
... In order to better prevent blood clots, the drugs ... acute ischaemia of the heart muscle, in addition to ... Efficiency in Health Care (IQWiG) has now investigated whether, ... coronary intervention (PCI), the combination of prasugrel plus ASA ...
Cached Medicine News:Health News:Flu Killed 115 Children Last Season: CDC 2Health News:Flu Killed 115 Children Last Season: CDC 3Health News:Study finds protein critical to breast cancer cell proliferation, migration 2Health News:Doctors Urged to Lead Battle Against Alcohol Abuse 2Health News:Cleveland Clinic researchers awarded NIH grant to study concussion-identifying blood test 2Health News:Cleveland Clinic researchers awarded NIH grant to study concussion-identifying blood test 3Health News:Not Enough Kids Drink Low-Fat Milk, U.S. Study Finds 2Health News:Prasugrel: Indications of an additional benefit for some patients, but also of greater harm 2Health News:Prasugrel: Indications of an additional benefit for some patients, but also of greater harm 3Health News:Prasugrel: Indications of an additional benefit for some patients, but also of greater harm 4
For the qualitative detection of IgG/IgM antibodies to B. burgdorferi...
... surgical-quality loupes available at manufacturer-direct ... innovative optical design, combining superior quality ... with maximum comfort, SheerVision loupes are ... worldwide. Make both a professional and ...
... surgical-quality loupes available at manufacturer-direct ... innovative optical design, combining superior quality ... with maximum comfort, SheerVision loupes are ... worldwide. Make both a professional and ...
... the first manufacturer to offer through-the-lens ... wearer. These next generation loupes feature ... ultra-lightweight design, and are multi-coated lens ... With SheerVision's proprietary SureFit system - ...
Medicine Products: